knowledge -WSS

knowledge

author：hotspot 2025-10-02 21:06:42 - browse：267

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： How to protect coverage of PrEP

entertainment

WSS

Scientists boost immune system in aging mice by making it youthful

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

FAMU bans football players from facility after release of rap video shot in team's locker room

There's no autism epidemic. It's an autism diagnosis epidemic

Vertex Pharmaceuticals may move headquarters in Boston

The response to Covid

entertainment

knowledge

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Transgender women dream of pregnancy via uterus transplants

The high cost of giving birth even with insurance

Burning questions about Delta and the next phase of the Covid pandemic

State Dept. review finds Biden bears some blame for Afghanistan failures

Novartis develops a rapidly manufactured CAR

Dobbs anniversary: the lost opportunity of abortion as health care

Roche subsidiary Foundation Medicine opens new headquarters

23andMe had bad news about my health. I wish a person had delivered it

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

leisure time

Readout Newsletter: Merck, Vertex, and Viking updates

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

FDA's naming rule on biosimilars has undermined competition

Clinic falsely told dozens they had Alzheimer's, suits say

FAMU bans football players from facility after release of rap video shot in team's locker room

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

entertainment

focus

focus

hotspot